A nanoparticle therapy to treat lung cancer and associated muscle wasting at the same time - Phys.org
A nanoparticle therapy to treat lung cancer and associated muscle wasting at the same time Phys.org
Lung Cancer News
FDA Submission Filed for Neladalkib in ALK+ Lung Cancer - Cure Today
FDA Submission Filed for Neladalkib in ALK+ Lung Cancer Cure Today
AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals - The Times of India
AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals The Times of India
Vaping likely causes oral and lung cancers, say researchers - scroll.in
Vaping likely causes oral and lung cancers, say researchers scroll.in
VIDEO: Osimertinib plus chemotherapy improves PFS in NSCLC with EGFR , TP53 mutations - Healio
VIDEO: Osimertinib plus chemotherapy improves PFS in NSCLC with EGFR , TP53 mutations Healio
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer - BioSpace
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer BioSpace
Checkpoint Inhibitors in NSCLC: FDA-Approved Immunotherapies, Pivotal Trials, and Insights from EMPOWER-Lung 3 - Managed Healthcare Executive
Checkpoint Inhibitors in NSCLC: FDA-Approved Immunotherapies, Pivotal Trials, and Insights from EMPOWER-Lung 3 Managed Healthcare Executive
Reconsidering Surgical Eligibility in Older Adults with Early-Stage NSCLC - Pharmacy Times
Reconsidering Surgical Eligibility in Older Adults with Early-Stage NSCLC Pharmacy Times
Dual perspective AI model achieves high accuracy in early lung cancer diagnosis - News-Medical
Dual perspective AI model achieves high accuracy in early lung cancer diagnosis News-Medical
Developers Submit NDA for Neladalkib in Pretreated ALK+ NSCLC - CancerNetwork
Developers Submit NDA for Neladalkib in Pretreated ALK+ NSCLC CancerNetwork
Non-Smokers and Lung Cancer: Part Two Insights - OSF HealthCare
Non-Smokers and Lung Cancer: Part Two Insights OSF HealthCare
2026 Lung Cancer Research Foundation Gala Spotlights Women - PR Newswire
2026 Lung Cancer Research Foundation Gala Spotlights Women PR Newswire
Lipid nanoparticles deliver dual therapy for lung cancer - Drug Target Review
Lipid nanoparticles deliver dual therapy for lung cancer Drug Target Review
A new AI model could help doctors detect lung cancer earlier - Medical Xpress
A new AI model could help doctors detect lung cancer earlier Medical Xpress
DNA Methylation Signatures Associated With Smoking Status Across Lung Cancer Subtypes Using The Cancer Genome Atlas (TCGA) Methylation Data - Cureus
DNA Methylation Signatures Associated With Smoking Status Across Lung Cancer Subtypes Using The Cancer Genome Atlas (TCGA) Methylation Data Cureus
Cancer survivor-backed biomarker testing bill moves forward in Tennessee - WSMV
Cancer survivor-backed biomarker testing bill moves forward in Tennessee WSMV
Jeff Yang: Enhancing Lung Cancer Screening Awareness via Targeted Public Health Strategies - Oncodaily
Jeff Yang: Enhancing Lung Cancer Screening Awareness via Targeted Public Health Strategies Oncodaily
Q&A with AdventHealth: Importance of lung cancer awareness and prevention - WFTV
Q&A with AdventHealth: Importance of lung cancer awareness and prevention WFTV
Florida Cancer Specialists & Research Institute Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer - Yahoo Finance
Florida Cancer Specialists & Research Institute Phase 3 Trial Demonstrates Initial Clinical Benefit of Novel Immunotherapy For Advanced Non-Small Cell Lung Cancer Yahoo Finance
Study finds link between air pollution and lung cancer rates - The Allegheny Front
Study finds link between air pollution and lung cancer rates The Allegheny Front
New Drug Application Submitted for Neladalkib in Advanced ALK+ NSCLC - Targeted Oncology
New Drug Application Submitted for Neladalkib in Advanced ALK+ NSCLC Targeted Oncology
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 - Business Wire
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 Business Wire
Tepmetko proves long-term survival in rare lung cancer a year after reimbursement - koreabiomed.com
Tepmetko proves long-term survival in rare lung cancer a year after reimbursement koreabiomed.com
Libtayo Shows 6-Year Survival Benefit in NSCLC Trial - Cure Today
Libtayo Shows 6-Year Survival Benefit in NSCLC Trial Cure Today
Global Lung Cancer Surgery Market | Rise at 5.9% CAGR | Medtronic, Ethicon, Intuitive Surgical Drive Precision Oncology Advancements - PR Newswire
Global Lung Cancer Surgery Market | Rise at 5.9% CAGR | Medtronic, Ethicon, Intuitive Surgical Drive Precision Oncology Advancements PR Newswire
KRAS G12C NSCLC: Promising Strategy as Cetuximab Boosts KRAS Inhibitor Response - Oncodaily
KRAS G12C NSCLC: Promising Strategy as Cetuximab Boosts KRAS Inhibitor Response Oncodaily
Gilead to Acquire Tubulis for Up to $5B, Expanding Cancer ADC Capabilities - Genetic Engineering and Biotechnology News
Gilead to Acquire Tubulis for Up to $5B, Expanding Cancer ADC Capabilities Genetic Engineering and Biotechnology News
Nuvalent Submits NDA for Neladalkib in ALK+ NSCLC After TKIs - Oncology Nursing News
Nuvalent Submits NDA for Neladalkib in ALK+ NSCLC After TKIs Oncology Nursing News
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1 - Nature
A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1 Nature
Nuvalent (NUVL) submits FDA New Drug Application for neladalkib in ALK+ lung cancer - Stock Titan
Nuvalent (NUVL) submits FDA New Drug Application for neladalkib in ALK+ lung cancer Stock Titan
New Technologies Make Lung Cancer Diagnosis, Treatment Quicker and Safer - U.S. News & World Report
New Technologies Make Lung Cancer Diagnosis, Treatment Quicker and Safer U.S. News & World Report
New AI tool predicts whether aggressive small cell lung cancer will respond to treatment - Medical Xpress
New AI tool predicts whether aggressive small cell lung cancer will respond to treatment Medical Xpress
Lung cancer survivor finds care, support and connection at UT MD Anderson - UT MD Anderson
Lung cancer survivor finds care, support and connection at UT MD Anderson UT MD Anderson
US pharma firm Gilead to acquire German biotech company Tubulis to boost cancer pipeline - Anadolu Ajansı
US pharma firm Gilead to acquire German biotech company Tubulis to boost cancer pipeline Anadolu Ajansı
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer - PR Newswire
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer PR Newswire
Family mourns Abilene man after he loses his battle with cancer - KTXS
Family mourns Abilene man after he loses his battle with cancer KTXS
The Inspiring Stories Behind the Run as One 4M Presented by JPMorgan Chase - New York Road Runners
The Inspiring Stories Behind the Run as One 4M Presented by JPMorgan Chase New York Road Runners
AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial - Nature
AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial Nature
Unexpected findings on lung cancer CT scans may point to other non-lung cancers, study finds - Brown University
Unexpected findings on lung cancer CT scans may point to other non-lung cancers, study finds Brown University
Nuvalent Files FDA Application for Lung Cancer Therapy - TipRanks
Nuvalent Files FDA Application for Lung Cancer Therapy TipRanks